Form C-AR — AlphaRose Therapeutics Inc
0001665160-25-000789 · filed Apr 29, 2025
Offering
- Target
- —
- Maximum
- —
- Security type
- —
- Price per security
- —
- Deadline
- —
- Oversubscription
- —
Issuer
- CIK
- 2051498
- Entity
- Corporation
- Jurisdiction
- DE
- Address
- 1401 LAVACA STREET, #851
AUSTIN, TX 78701 - Phone
- —
Most recent fiscal year financials
- Total assets
- $614,498
- Cash
- —
- Short-term debt
- $81,098
- Long-term debt
- $1,070,000
- Revenues
- —
- COGS
- —
- Taxes paid
- —
- Net income
- $-625,253
View the original filing on SEC EDGAR ↗